Distinct scavenger receptor expression and function in the human CD14+/CD16+monocyte subset.

The CD14+/CD16+subset of human blood monocytes, which expresses low levels of the lipopolysaccharide receptor CD14 and high levels of the Fc receptor CD16 and exhibits features of mature tissue macrophages, is expanded in certain inflammatory conditions and may be relevant in atherosclerosis. Scavenger receptors (ScR) are important for lipid accumulation into macrophage-derived foam cells in atherogenesis and for the clearance of pathogens. Hence, we compared the function and expression of ScR in CD33lowCD16+ and CD33highCD14++ monocyte subsets. Double immunofluorescence analysis of isolated monocytes revealed that the CD33low subset showed lower specific, ScR-mediated binding of DiI-labeled modified low-density lipoproteins (LDL) than CD33highcells. Differences in modified LDL binding between subsets were accompanied by changes in mRNA expression. RT-PCR in sorted cells indicated lower ScR class A type I/II (ScR-AI/II) mRNA levels in CD14+/CD16+than in CD14++ cells, whereas CD36 transcripts were unaltered. This was paralleled by findings in mostly CD16+ monocyte-derived macrophages showing a marked reduction in ScR-mediated binding of acetylated LDL, but not in the binding of oxidized LDL, and lower expression of ScR-AI/II mRNA, but not CD36 transcripts, after exposure to tumor necrosis factor-α for 48 h in vitro. Thus the subset of CD14+/CD16+monocytes shows distinct ScR function and expression, possibly reflecting a preactivation by cytokines with a predilection for specific inflammatory or vascular conditions, e.g., atherogenesis.

[1]  T. Springer,et al.  Role of a , & lntegrin Avidity in Transendothelial Chemotaxis of Mononuclear Cells ‘ , 2001 .

[2]  R. Lorenz,et al.  The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. , 1999, Biochemical pharmacology.

[3]  W. Erl,et al.  Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. , 1998, Atherosclerosis.

[4]  M. Harada‐Shiba,et al.  Acquisition of Secretion of Transforming Growth Factor-β1 Leads to Autonomous Suppression of Scavenger Receptor Activity in a Monocyte-Macrophage Cell Line, THP-1* , 1998, The Journal of Biological Chemistry.

[5]  T. Kodama,et al.  The Macrophage Scavenger Receptor Type A Is Expressed by Activated Macrophages and Protects the Host Against Lethal Endotoxic Shock , 1997, The Journal of experimental medicine.

[6]  T. Springer,et al.  Role of alpha L beta 2 integrin avidity in transendothelial chemotaxis of mononuclear cells. , 1997, Journal of immunology.

[7]  G. Schmitz,et al.  Scavenging, signalling and adhesion coupling in macrophages: implications for atherogenesis , 1997, Current opinion in lipidology.

[8]  P. Boekstegers,et al.  Cytokine production precedes the expansion of CD14+CD16+ monocytes in human sepsis: a case report of a patient with self-induced septicemia. , 1997, Shock.

[9]  P. Weber,et al.  Acetylated LDL endocytosis by the human monocytic Mono Mac 6sr cells is not mediated by the macrophage type I and II scavenger receptors. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[10]  K. Murao,et al.  Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by Cytokines* , 1997, The Journal of Biological Chemistry.

[11]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[12]  A. Sica,et al.  Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes , 1997, The Journal of experimental medicine.

[13]  M. Freeman.  Scavenger receptors in atherosclerosis , 1997, Current opinion in hematology.

[14]  G. Schmitz,et al.  Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[15]  D. Teupser,et al.  Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. , 1996, Biochimica et biophysica acta.

[16]  H. Ziegler-Heitbrock,et al.  Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. , 1996, Immunology today.

[17]  W. Erl,et al.  Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells. , 1996, Biochemical pharmacology.

[18]  T. Springer,et al.  Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis , 1996, The Journal of cell biology.

[19]  R. Silverstein,et al.  Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[20]  A. C. Nicholson,et al.  Inhibition of Macrophage Scavenger Receptor Activity by Tumor Necrosis Factor- Is Transcriptionally and Post-transcriptionally Regulated (*) , 1996, The Journal of Biological Chemistry.

[21]  L. Yesner,et al.  Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. , 1996, Blood.

[22]  T. Sternsdorf,et al.  Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. , 1996, Blood.

[23]  T. Springer,et al.  Sequential Regulation of ct4131 and ct5131 Integrin Avidity by CC Chemokines in Monocytes: Implications for Transendothelial Chemotaxis , 1996 .

[24]  T. V. van Berkel,et al.  Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[25]  S. Yamashita,et al.  Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. , 1995, The Journal of clinical investigation.

[26]  W. Erl,et al.  Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. , 1995, Journal of immunology.

[27]  W. Erl,et al.  Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. , 1995, Circulation.

[28]  G. Vanham,et al.  Expression patterns of Fcγ receptors, HLA‐DR and selected adhesion molecules on monocytes from normal and HIV‐infected individuals , 1994, Clinical and experimental immunology.

[29]  W. Erl,et al.  Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[30]  S. Gordon,et al.  Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function , 1994, The Journal of experimental medicine.

[31]  T. Kodama,et al.  Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  B. Passlick,et al.  The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients , 1993 .

[33]  B. Passlick,et al.  The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages , 1993, European journal of immunology.

[34]  R. Furth,et al.  Monocyte adherence to human vascular endothelium , 1993, Behring Institute Mitteilungen.

[35]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[36]  B. Passlick,et al.  The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. , 1993, Blood.

[37]  G. Hansson,et al.  Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. , 1992, The Journal of clinical investigation.

[38]  A. Fogelman,et al.  Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. , 1992, Journal of immunology.

[39]  R. Assoian,et al.  Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. , 1991, The Journal of biological chemistry.

[40]  D. Steinberg,et al.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Passlick,et al.  Identification and characterization of a novel monocyte subpopulation in human peripheral blood. , 1989, Blood.

[42]  B. Passlick,et al.  The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. , 1988, Hybridoma.

[43]  L. Boxer,et al.  Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. , 1981, Journal of immunology.

[44]  R. Seeger,et al.  Volumetric and functional heterogeneity of human monocytes. , 1980, The Journal of clinical investigation.